Patents by Inventor Lothar Faerber

Lothar Faerber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of 5-HTreceptor antagonists for treating musculoskeletal diseases
    Patent number: 7393857
    Abstract: The present invention relates to a new use for compounds having 5-HT3 (serotonin M) receptor antagonist activity, especially tropisetron, for the manufacture of a pharmaceutical composition for the treatment of a non-inflammatory local disease of the musculo-sceletal system, of a local irritation condition of a joint or tendon sheath, or for the local treatment a local manifestation at the locomotor apparatus of an inflammatory disease except for a crystal induced arthritis and a living pathogen induced inflammatory disease condition as long as the living pathogen is still present.
    Type: Grant
    Filed: August 21, 2002
    Date of Patent: July 1, 2008
    Assignee: Novasearch AG
    Inventors: Wolfgang Mueller, Thomas Stratz, Lothar Faerber
  • Use of 5-HT(3) receptor antagonists for treating musculoeskeletal diseases
    Publication number: 20020002197
    Abstract: The present invention relates to a new use for compounds having 5-HT3 (serotonin M) receptor antagonist activity, especially tropisetron, for the manufacture of a pharmaceutical composition for the treatment of a non-inflammatory local disease of the musculo-sceletal system, of a local irritation condition of a joint or tendon sheath, or for the local treatment a local manifestation at the locomotor apparatus of an inflammatory disease except for a crystal induced arthritis and a living pathogen induced inflammatory disease condition as long as the living pathogen is still present.
    Type: Application
    Filed: August 14, 2001
    Publication date: January 3, 2002
    Inventors: Wolfgang Mueller, Thomas Stratz, Lothar Faerber
  • Systemic use of 5-HT3 receptor antagonists against rheumatic inflammatory processes
    Publication number: 20010056110
    Abstract: The present invention relates to a new use for compounds having 5-HT3 (serotonin M) receptor antagonist activity, especially tropisetron, for the manufacture of a pharmaceutical composition for the systemic treatment of an inflammatory rheumatic or rheumatoid disease other than crystal induced arthritis and other than living pathogen induced inflammatory diseases as long as the living pathogen is still present.
    Type: Application
    Filed: August 16, 2001
    Publication date: December 27, 2001
    Inventors: Lothar Faerber, Wolfgang Mueller, Thomas Stratz